– Reuters Citing Tweet
Cardiovascular Reports Start Of Enrollment In First In-Human Trial Of Coronary Everolimus Drug-Coated Balloon
Cardiovascular Systems, Inc. (CSI®) (NASDAQ:CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease,